← Eichor
Study identifier: NCT07445438 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility of a Multi-omics Platform for Hematological Malignancies

Condition: Myeloma Multiple · Chronic Leukemia · Acute Leukemia  ·  Sponsor: Azienda Ospedaliero-Universitaria di Parma

PhaseNA
Planned participants1040
Who can joinAll sexes, 2 Years to no upper limit
Healthy volunteersNo

About this study

This is a biological study based on a collaborative effort involving several Italian haematology centres (including the coordinating centre). The study will be conducted retrospectively and prospectively using bone marrow (BM) or peripheral blood (PB) samples, lymph node or tissue biopsies with metastatic involvement, and other biological fluids, such as cerebrospinal fluid and pathological pleural effusion.

This description comes directly from the study's public registry record.

Talk to the study team

Giovanni Roti, Associate Professor  ·  +39 0521 702200  ·  giovanni.roti@unipr.it

Always discuss trial participation with your own doctor first.

Locations (1)

University of ParmaParma, PR, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07445438